CIK 0001560293 · <br>Emerging growth company
Tenon Medical, Inc.
Sign in to watch- Ticker
- TNON
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455574718
- Phone
- (408) 649-5760
- Business address
- 104 COOPER CT., LOS GATOS, CA, 95032
Securities
- TNON Common Stock Nasdaq
- TNONW Warrant Nasdaq
- Open-market buys, last 90 days
- $500,223
- in 4 filings
- Open-market sales, last 90 days
- $605,668
- in 5 filings
Net −$105,445. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-13 | HOWARD IVAN Director | Grant or award · Restricted Stock Units | +21,464 | 21,464 | ||
| 2025-09-03 | Williamson Kevin Chief Financial Officer | Option exercise | +2,083 | 2,083 | ||
| 2025-09-03 | Williamson Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −2,083 | 4,167 | ||
| 2025-05-22 | WEIGLE ROBERT K Director | Option exercise | +78 | 233 | ||
| 2025-05-22 | WEIGLE ROBERT K Director | Option exercise · Restricted Stock Units | −78 | 0 | ||
| 2025-05-22 | HOWARD IVAN Director | Option exercise | +78 | 1,057 | ||
| 2025-05-22 | HOWARD IVAN Director | Option exercise · Restricted Stock Units | −78 | 0 | ||
| 2024-11-05 | Williamson Kevin Chief Financial Officer | Grant or award · Restricted Stock Units | +6,250 | 6,250 | ||
| 2024-05-22 | WEIGLE ROBERT K Director | Option exercise | +78 | 155 | ||
| 2024-05-22 | WEIGLE ROBERT K Director | Option exercise · Restricted Stock Units | −78 | 78 | ||
| 2024-05-22 | HOWARD IVAN Director | Option exercise | +78 | 979 | ||
| 2024-05-22 | HOWARD IVAN Director | Option exercise · Restricted Stock Units | −78 | 78 | ||
| 2024-05-08 | Jacques Kristine M Director | Grant or award · Restricted Stock Units | +1,750 | 1,750 | ||
| 2023-06-14 | VAN DICK STEVEN M Chief Financial Officer | Purchase | +50,000 | $0.27 | $14K | 100,416 |
| 2023-05-23 | FOSTER STEVEN M CEO and President | Sale | −27,791 | $1.26 | $35K | 44,686 |
| 2023-05-23 | GINN RICHARD Chief Technology Officer | Sale | −64,990 | $1.26 | $82K | 85,318 |
| 2023-05-22 | Ferrari Richard Director | Option exercise | +91,300 | $1.62 | $148K | 183,514 |
| 2023-05-22 | Hochschuler Stephen Director | Option exercise | +6,207 | $1.62 | $10K | 25,907 |
| 2023-05-22 | FOSTER STEVEN M CEO and President | Option exercise | +72,477 | $1.62 | $117K | 72,477 |
| 2023-05-22 | HOWARD IVAN Director | Option exercise | +6,207 | $1.62 | $10K | 72,125 |
Page 5 of 6 · 104 trades